CA2374073A1 - Nouveaux polypeptides et acides nucleiques codant ces polypeptides - Google Patents

Nouveaux polypeptides et acides nucleiques codant ces polypeptides Download PDF

Info

Publication number
CA2374073A1
CA2374073A1 CA002374073A CA2374073A CA2374073A1 CA 2374073 A1 CA2374073 A1 CA 2374073A1 CA 002374073 A CA002374073 A CA 002374073A CA 2374073 A CA2374073 A CA 2374073A CA 2374073 A1 CA2374073 A1 CA 2374073A1
Authority
CA
Canada
Prior art keywords
polypeptide
nucleic acid
novx
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002374073A
Other languages
English (en)
Inventor
Raymond J. Taupier Jr.
Kumud Majumder
Steven K. Spaderna
Glenda Smithson
Peter S. Mezes
Corine A. M. Vernet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2374073A1 publication Critical patent/CA2374073A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne de nouveaux polynucléotides NOVX isolés et des polypeptides codés par ces polynucléotides NOVX. L'invention concerne également des anticorps qui se fixent de façon immunospécifique sur un polypeptide NOVX ou tout dérivé, variant, mutant ou fragment du polypeptide, polynucléotide ou anticorps NOVX. L'invention concerne également des méthodes dans lesquelles ce polypeptide, ce polynucléotide et cet anticorps NOVX sont utilisés pour détecter et traiter une large gamme d'états pathologiques, ainsi que pour d'autres utilisations.
CA002374073A 2000-03-20 2001-03-20 Nouveaux polypeptides et acides nucleiques codant ces polypeptides Abandoned CA2374073A1 (fr)

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US19083500P 2000-03-20 2000-03-20
US19076800P 2000-03-20 2000-03-20
US60/190,835 2000-03-20
US60/190,768 2000-03-20
US19097200P 2000-03-22 2000-03-22
US19119900P 2000-03-22 2000-03-22
US60/191,199 2000-03-22
US60/190,972 2000-03-22
US19194700P 2000-03-24 2000-03-24
US60/191,947 2000-03-24
US19298400P 2000-03-28 2000-03-28
US19266500P 2000-03-28 2000-03-28
US19265700P 2000-03-28 2000-03-28
US19266400P 2000-03-28 2000-03-28
US60/192,664 2000-03-28
US60/192,984 2000-03-28
US60/192,665 2000-03-28
US60/192,657 2000-03-28
US19283600P 2000-03-29 2000-03-29
US60/192,836 2000-03-29
US19384300P 2000-03-31 2000-03-31
US60/193,843 2000-03-31
PCT/US2001/009093 WO2001070978A2 (fr) 2000-03-20 2001-03-20 Nouveaux polypeptides et acides nucleiques codant ces polypeptides

Publications (1)

Publication Number Publication Date
CA2374073A1 true CA2374073A1 (fr) 2001-09-27

Family

ID=27582713

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002374073A Abandoned CA2374073A1 (fr) 2000-03-20 2001-03-20 Nouveaux polypeptides et acides nucleiques codant ces polypeptides

Country Status (5)

Country Link
EP (1) EP1232266A2 (fr)
JP (1) JP2003527859A (fr)
AU (1) AU4592001A (fr)
CA (1) CA2374073A1 (fr)
WO (1) WO2001070978A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003527859A (ja) * 2000-03-20 2003-09-24 キュラジェン コーポレイション 新規ポリペプチドおよびそれをコードする核酸
AU2001259565A1 (en) * 2000-05-04 2001-11-12 Incyte Genomics, Inc. Proteases
US20010051361A1 (en) * 2000-05-15 2001-12-13 Wei Shao Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2001096562A1 (fr) * 2000-06-13 2001-12-20 Merck Patent Gmbh Recepteurs couples aux proteines g, du type des recepteurs de l'hormone liberant la thyrotropine (gprfwk1)
WO2001098340A2 (fr) * 2000-06-23 2001-12-27 Bayer Aktiengesellschaft Regulation d'une enzyme du type protease mastocytaire humaine 6
CN1549858A (zh) * 2000-11-27 2004-11-24 阿伦纳药品公司 内源和非内源型人g蛋白偶联受体
EP1343888A2 (fr) * 2000-12-14 2003-09-17 Bayer Aktiengesellschaft Regulation du recepteur humain de type chimiokine
JPWO2003027142A1 (ja) * 2001-09-21 2005-01-06 山之内製薬株式会社 新規g蛋白質共役型受容体
US8516137B2 (en) * 2009-11-16 2013-08-20 Microsoft Corporation Managing virtual hard drives as blobs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658758A (en) * 1995-03-24 1997-08-19 Human Genome Sciences Inc Polynucleotides encoding cytostatin I
US6063594A (en) * 1997-01-31 2000-05-16 Incyte Pharmaceuticals, Inc. DNA encoding a novel human anion channel
JP2003527859A (ja) * 2000-03-20 2003-09-24 キュラジェン コーポレイション 新規ポリペプチドおよびそれをコードする核酸
JP2004516817A (ja) * 2000-07-27 2004-06-10 インサイト・ゲノミックス・インコーポレイテッド Gタンパク質共役受容体

Also Published As

Publication number Publication date
AU4592001A (en) 2001-10-03
WO2001070978A3 (fr) 2002-06-27
EP1232266A2 (fr) 2002-08-21
WO2001070978A2 (fr) 2001-09-27
JP2003527859A (ja) 2003-09-24

Similar Documents

Publication Publication Date Title
US20050287564A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20060063200A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20030185815A1 (en) Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
CA2374073A1 (fr) Nouveaux polypeptides et acides nucleiques codant ces polypeptides
US20040002120A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20030148485A1 (en) Novel polypeptides and nucleic acids encoding same
CA2448073A1 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
US20030202971A1 (en) Novel polypeptides and nucleic acids encoding same
US20030224982A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2442729A1 (fr) Polypeptides therapeutiques, acides nucleiques les codant, et procedes d'utilisation
US20040014053A1 (en) Novel proteins and nucleic acids encoding same
US20060211031A1 (en) Novel proteins and nucleic acids encoding same
CA2402248A1 (fr) Nouveaux polypeptides et acides nucleiques les codant
US20030216308A1 (en) Novel polypeptides and nucleic acids encoding same
US20040058862A1 (en) Novel polypeptides and nucleic acids encoding the same
US20040029790A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
US20030208039A1 (en) Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
CA2442739A1 (fr) Nouveaux anticorps se liant a des polypeptides antigeniques, acides nucleiques codant pour ces antigenes, et procedes d'utilisation de ceux-ci
WO2002081629A2 (fr) Nouvelles proteines humaines, polynucleotides codant celles-ci et procede d'utilisation de ceux-ci
US20020037850A1 (en) Novel polypeptides and nucleic acids encoding same
US20030077774A1 (en) Novel polypeptides and nucleic acids encoding same
US20030077794A1 (en) Novel polypeptides and nucleic acids encoding same
US20030199465A1 (en) Novel polypeptides and nucleic acids encoding same
US20030224367A1 (en) Novel polypeptides and nucleic acids encoding same
US20040010120A1 (en) Novel polypeptides and nucleic acids encoding same

Legal Events

Date Code Title Description
FZDE Dead